Trenbolone Hexahydrobenzylcarbonate (Parabolan) – ZPHC

Trenbolone Hexahydrobenzylcarbonate, commonly known as Parabolan, is a long-acting anabolic-androgenic steroid widely regarded for its extreme potency in strength and physique enhancement contexts. It is used primarily to promote significant increases in muscle mass, strength, and overall body recomposition.

General Overview

Parabolan is a long-ester form of trenbolone, designed for slow and sustained release in the body. It is known for producing rapid improvements in muscle density, hardness, and overall performance without water retention. It is often considered one of the most powerful anabolic compounds available due to its strong binding affinity to androgen receptors and its pronounced effects on nutrient utilization and body composition.

Pharmacological Profile

Anabolic activity: Extremely high (around 500% relative scale)
Androgenic activity: Extremely high (around 500% relative scale)
Aromatization: None (does not convert to estrogen)
Progestogenic activity: High
Half-life: Approximately 5–7 days
Administration: Injectable
Hepatotoxicity: Moderate

Noted Effects

Rapid increase in lean muscle mass
Significant improvements in strength and power output
Enhanced fat loss and body recomposition
Increased muscle hardness and density
Improved nutrient efficiency and nitrogen retention
Enhanced endurance and training performance
Increased red blood cell production, improving oxygen delivery

General Characteristics

Very strong anabolic and androgenic response
No estrogen-related water retention due to lack of aromatization
Long-acting ester allowing less frequent administration compared to shorter trenbolone forms
Associated with strong systemic stress on the body

 Side Effects

Severe suppression of natural testosterone production
Strong androgenic effects such as acne, hair loss, and increased aggression
Elevated blood pressure and cardiovascular strain
Increased body temperature and sweating
Progestogenic-related effects, potentially contributing to hormonal imbalance
Sleep disturbance and mood changes in some users
Possible gynecomastia risk through non-estrogenic pathways (progestin-related)